Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Fujii

Showing results (61-70 of 1,453) with videos related to

Pageof 146
Sort By:
American Journal of Hematology|August 1, 1990
Recent progress in the molecular genetic analysis of erythroenzymopathyH Fujii, S Miwa
Clinical Biochemistry|April 1, 1990
Pyruvate kinase deficiencyS Miwa, H Fujii
Josai Shika Daigaku Kiyo. the Bulletin of the Josai Dental University|January 1, 1984
[A case of pelvic kidney with several vascular anomalies]H Hanai, H Fujii
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 1, 1997
[Detection of P-glycoprotein and its clinical significance]N Tanigawa, H Fujii
Gan No Rinsho. Japan Journal of Cancer Clinics|July 1, 1983
[Clinico-pathological studies of tumor-forming type of multiple myeloma]H Fujii, S Seki
The Japanese Journal of Antibiotics|June 1, 1981
[Amikacin therapy for serious infections in hematopoietic disorders (author's transl)]H Fujii, T Shimizu
Hepato-Gastroenterology|September 1, 1995
Optimal locoregional immunochemotherapy after tumor-mass reduction for advanced hepatocellular carcinomaM Yamamoto, H Fujii
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 1, 1986
[Molecular analysis of erythroenzymopathies--phosphoglycerate kinase deficiency]K Tani, H Fujii
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 1, 1979
[Erythroenzymopathies in Japan (author's transl)]H Fujii, S Miwa
Current Medicinal Chemistry|May 25, 2006
Rational drug design of selective epsilon opioid receptor agonist TAN-821 and antagonist TAN-1014H Fujii, H Nagase
Pageof 146

Showing results (61-70 of 1,453) with videos related to

Sort By:
Pageof 146
American Journal of Hematology|August 1, 1990
Recent progress in the molecular genetic analysis of erythroenzymopathyH Fujii, S Miwa
Clinical Biochemistry|April 1, 1990
Pyruvate kinase deficiencyS Miwa, H Fujii
Josai Shika Daigaku Kiyo. the Bulletin of the Josai Dental University|January 1, 1984
[A case of pelvic kidney with several vascular anomalies]H Hanai, H Fujii
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 1, 1997
[Detection of P-glycoprotein and its clinical significance]N Tanigawa, H Fujii
Gan No Rinsho. Japan Journal of Cancer Clinics|July 1, 1983
[Clinico-pathological studies of tumor-forming type of multiple myeloma]H Fujii, S Seki
The Japanese Journal of Antibiotics|June 1, 1981
[Amikacin therapy for serious infections in hematopoietic disorders (author's transl)]H Fujii, T Shimizu
Hepato-Gastroenterology|September 1, 1995
Optimal locoregional immunochemotherapy after tumor-mass reduction for advanced hepatocellular carcinomaM Yamamoto, H Fujii
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 1, 1986
[Molecular analysis of erythroenzymopathies--phosphoglycerate kinase deficiency]K Tani, H Fujii
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 1, 1979
[Erythroenzymopathies in Japan (author's transl)]H Fujii, S Miwa
Current Medicinal Chemistry|May 25, 2006
Rational drug design of selective epsilon opioid receptor agonist TAN-821 and antagonist TAN-1014H Fujii, H Nagase
Pageof 146